Bantigue, Retchelyn A.

HRN: 21-36-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2022
CEFUROXIME 1.5GM (VIAL)
06/10/2022
06/10/2022
IVTT
1.5
1 Dose Only
Prophylaxis For OR
Waiting Final Action 
06/09/2022
CEFUROXIME 750MG (VIAL)
06/10/2022
06/16/2022
IV
750mg
Q8H
Prophylaxis For OR
06/09/2022
CEFUROXIME 750MG (VIAL)
06/10/2022
06/16/2022
IV
750mg
Q8H
Prophylaxis For OR
06/09/2022
CEFUROXIME 750MG (VIAL)
06/10/2022
06/16/2022
IV
750mg
Q8H
Prophylaxis For OR
06/09/2022
CEFUROXIME 750MG (VIAL)
06/10/2022
06/16/2022
IV
750mg
Q8H
Prophylaxis For OR
06/09/2022
CEFUROXIME 1.5GM (VIAL)
06/10/2022
06/16/2022
IV
1.5
Q8H
Prophylaxis For OR
Waiting Final Action 
06/11/2022
CEFUROXIME 500MG (TAB)
06/11/2022
06/18/2022
PO
500mg
Q12H
S/p TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: